nodes	percent_of_prediction	percent_of_DWPC	metapath
Theobromine—Caffeine—ATM—urinary bladder cancer	0.0729	1	CrCbGaD
Theobromine—CYP1A2—urine—urinary bladder cancer	0.0539	0.129	CbGeAlD
Theobromine—CYP2E1—Etoposide—urinary bladder cancer	0.0533	0.44	CbGbCtD
Theobromine—CYP2E1—urine—urinary bladder cancer	0.0485	0.116	CbGeAlD
Theobromine—CYP1A2—Fluorouracil—urinary bladder cancer	0.0369	0.305	CbGbCtD
Theobromine—PDE4B—prostate gland—urinary bladder cancer	0.0315	0.0753	CbGeAlD
Theobromine—CYP1A2—Etoposide—urinary bladder cancer	0.0308	0.255	CbGbCtD
Theobromine—ADORA1—renal system—urinary bladder cancer	0.029	0.0694	CbGeAlD
Theobromine—ADORA1—urethra—urinary bladder cancer	0.0285	0.0681	CbGeAlD
Theobromine—ADORA2A—female reproductive system—urinary bladder cancer	0.0269	0.0644	CbGeAlD
Theobromine—ADORA1—female reproductive system—urinary bladder cancer	0.0233	0.0556	CbGeAlD
Theobromine—PDE4B—urethra—urinary bladder cancer	0.0211	0.0504	CbGeAlD
Theobromine—ADORA1—vagina—urinary bladder cancer	0.021	0.0502	CbGeAlD
Theobromine—CYP2E1—prostate gland—urinary bladder cancer	0.0174	0.0416	CbGeAlD
Theobromine—PDE4B—female reproductive system—urinary bladder cancer	0.0172	0.0411	CbGeAlD
Theobromine—PDE4B—vagina—urinary bladder cancer	0.0156	0.0372	CbGeAlD
Theobromine—CYP2E1—seminal vesicle—urinary bladder cancer	0.0147	0.0352	CbGeAlD
Theobromine—ADORA1—lymph node—urinary bladder cancer	0.0136	0.0325	CbGeAlD
Theobromine—CYP1A2—renal system—urinary bladder cancer	0.0132	0.0315	CbGeAlD
Theobromine—CYP2E1—renal system—urinary bladder cancer	0.0119	0.0284	CbGeAlD
Theobromine—CYP2E1—urethra—urinary bladder cancer	0.0117	0.0279	CbGeAlD
Theobromine—PDE4B—lymph node—urinary bladder cancer	0.0101	0.024	CbGeAlD
Theobromine—CYP2E1—female reproductive system—urinary bladder cancer	0.0095	0.0227	CbGeAlD
Theobromine—CYP1A2—Biological oxidations—UGT2B7—urinary bladder cancer	0.0018	0.00464	CbGpPWpGaD
Theobromine—CYP2E1—Biological oxidations—NAT2—urinary bladder cancer	0.00179	0.00462	CbGpPWpGaD
Theobromine—CYP1A2—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.00177	0.00458	CbGpPWpGaD
Theobromine—CYP2E1—Metapathway biotransformation—NAT2—urinary bladder cancer	0.00177	0.00456	CbGpPWpGaD
Theobromine—ADORA1—Circadian rythm related genes—CDK4—urinary bladder cancer	0.00173	0.00446	CbGpPWpGaD
Theobromine—ADORA2A—Circadian rythm related genes—TYMS—urinary bladder cancer	0.00171	0.00442	CbGpPWpGaD
Theobromine—ADORA2A—Circadian rythm related genes—NCOR1—urinary bladder cancer	0.00169	0.00437	CbGpPWpGaD
Theobromine—CYP1A2—Biological oxidations—CYP4B1—urinary bladder cancer	0.00162	0.00418	CbGpPWpGaD
Theobromine—CYP1A2—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.0016	0.00412	CbGpPWpGaD
Theobromine—ADORA1—Circadian rythm related genes—PPARG—urinary bladder cancer	0.00157	0.00405	CbGpPWpGaD
Theobromine—ADORA2A—Circadian rythm related genes—FAS—urinary bladder cancer	0.00152	0.00392	CbGpPWpGaD
Theobromine—PDE4B—G Protein Signaling Pathways—KRAS—urinary bladder cancer	0.00151	0.00391	CbGpPWpGaD
Theobromine—CYP1A2—Phase II conjugation—HPGDS—urinary bladder cancer	0.00147	0.0038	CbGpPWpGaD
Theobromine—CYP2E1—Biological oxidations—HPGDS—urinary bladder cancer	0.00143	0.0037	CbGpPWpGaD
Theobromine—CYP1A2—Phase II conjugation—GSTT1—urinary bladder cancer	0.00143	0.00368	CbGpPWpGaD
Theobromine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	0.00139	0.0036	CbGpPWpGaD
Theobromine—CYP2E1—Biological oxidations—GSTT1—urinary bladder cancer	0.00139	0.00359	CbGpPWpGaD
Theobromine—CYP1A2—Arachidonic acid metabolism—GPX1—urinary bladder cancer	0.00137	0.00353	CbGpPWpGaD
Theobromine—ADORA2A—NGF signalling via TRKA from the plasma membrane—FGFR3—urinary bladder cancer	0.00134	0.00346	CbGpPWpGaD
Theobromine—ADORA2A—Circadian rythm related genes—CDK4—urinary bladder cancer	0.00133	0.00344	CbGpPWpGaD
Theobromine—PDE4B—G Protein Signaling Pathways—HRAS—urinary bladder cancer	0.00129	0.00332	CbGpPWpGaD
Theobromine—ADORA2A—Circadian rythm related genes—PPARG—urinary bladder cancer	0.00121	0.00313	CbGpPWpGaD
Theobromine—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—urinary bladder cancer	0.0012	0.0031	CbGpPWpGaD
Theobromine—ADORA1—Circadian rythm related genes—PTEN—urinary bladder cancer	0.00108	0.00278	CbGpPWpGaD
Theobromine—CYP1A2—Biological oxidations—NAT2—urinary bladder cancer	0.00108	0.00278	CbGpPWpGaD
Theobromine—CYP1A2—Metapathway biotransformation—NAT2—urinary bladder cancer	0.00106	0.00274	CbGpPWpGaD
Theobromine—ADORA1—G alpha (i) signalling events—CXCL8—urinary bladder cancer	0.00106	0.00273	CbGpPWpGaD
Theobromine—CYP1A2—Aryl Hydrocarbon Receptor—RB1—urinary bladder cancer	0.00105	0.0027	CbGpPWpGaD
Theobromine—ADORA2A—NGF signalling via TRKA from the plasma membrane—RHOA—urinary bladder cancer	0.00103	0.00267	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by NGF—FGFR3—urinary bladder cancer	0.00103	0.00266	CbGpPWpGaD
Theobromine—ADORA1—Circadian rythm related genes—EP300—urinary bladder cancer	0.00103	0.00265	CbGpPWpGaD
Theobromine—CYP1A2—Phase II conjugation—GSTP1—urinary bladder cancer	0.00099	0.00255	CbGpPWpGaD
Theobromine—CYP2E1—Biological oxidations—GSTP1—urinary bladder cancer	0.000963	0.00249	CbGpPWpGaD
Theobromine—ADORA2A—NGF signalling via TRKA from the plasma membrane—ERBB2—urinary bladder cancer	0.000957	0.00247	CbGpPWpGaD
Theobromine—CYP2E1—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.00095	0.00245	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—HDAC4—urinary bladder cancer	0.000948	0.00245	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—HDAC4—urinary bladder cancer	0.000937	0.00242	CbGpPWpGaD
Theobromine—CYP1A2—Phase II conjugation—GSTM1—urinary bladder cancer	0.000909	0.00235	CbGpPWpGaD
Theobromine—CYP2E1—Biological oxidations—GSTM1—urinary bladder cancer	0.000885	0.00228	CbGpPWpGaD
Theobromine—CYP2E1—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000873	0.00225	CbGpPWpGaD
Theobromine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—urinary bladder cancer	0.000861	0.00222	CbGpPWpGaD
Theobromine—CYP1A2—Biological oxidations—HPGDS—urinary bladder cancer	0.000861	0.00222	CbGpPWpGaD
Theobromine—ADORA1—Class A/1 (Rhodopsin-like receptors)—CXCL8—urinary bladder cancer	0.000841	0.00217	CbGpPWpGaD
Theobromine—CYP1A2—Biological oxidations—GSTT1—urinary bladder cancer	0.000835	0.00216	CbGpPWpGaD
Theobromine—ADORA2A—Circadian rythm related genes—PTEN—urinary bladder cancer	0.000832	0.00215	CbGpPWpGaD
Theobromine—ADORA2A—NGF signalling via TRKA from the plasma membrane—CDKN1A—urinary bladder cancer	0.000818	0.00211	CbGpPWpGaD
Theobromine—ADORA2A—NGF signalling via TRKA from the plasma membrane—PTEN—urinary bladder cancer	0.000816	0.00211	CbGpPWpGaD
Theobromine—CYP1A2—Arachidonic acid metabolism—PTGS2—urinary bladder cancer	0.000806	0.00208	CbGpPWpGaD
Theobromine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—urinary bladder cancer	0.000798	0.00206	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by NGF—RHOA—urinary bladder cancer	0.000795	0.00205	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—GLI1—urinary bladder cancer	0.000795	0.00205	CbGpPWpGaD
Theobromine—ADORA2A—Circadian rythm related genes—EP300—urinary bladder cancer	0.000793	0.00205	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—GLI1—urinary bladder cancer	0.000785	0.00203	CbGpPWpGaD
Theobromine—ADORA2A—NGF signalling via TRKA from the plasma membrane—SRC—urinary bladder cancer	0.000757	0.00195	CbGpPWpGaD
Theobromine—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—urinary bladder cancer	0.000753	0.00194	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by NGF—ERBB2—urinary bladder cancer	0.000736	0.0019	CbGpPWpGaD
Theobromine—ADORA1—Circadian rythm related genes—TP53—urinary bladder cancer	0.000735	0.0019	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—HDAC4—urinary bladder cancer	0.000732	0.00189	CbGpPWpGaD
Theobromine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—urinary bladder cancer	0.000716	0.00185	CbGpPWpGaD
Theobromine—CYP1A2—Aryl Hydrocarbon Receptor—EP300—urinary bladder cancer	0.000716	0.00185	CbGpPWpGaD
Theobromine—CYP1A2—Aryl Hydrocarbon Receptor—SRC—urinary bladder cancer	0.000697	0.0018	CbGpPWpGaD
Theobromine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—urinary bladder cancer	0.000697	0.0018	CbGpPWpGaD
Theobromine—ADORA2A—NGF signalling via TRKA from the plasma membrane—EGFR—urinary bladder cancer	0.000663	0.00171	CbGpPWpGaD
Theobromine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—urinary bladder cancer	0.000649	0.00168	CbGpPWpGaD
Theobromine—ADORA1—GPCR ligand binding—CXCL8—urinary bladder cancer	0.00064	0.00165	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by NGF—CDKN1A—urinary bladder cancer	0.000629	0.00162	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by NGF—PTEN—urinary bladder cancer	0.000627	0.00162	CbGpPWpGaD
Theobromine—ADORA2A—NGF signalling via TRKA from the plasma membrane—KRAS—urinary bladder cancer	0.000626	0.00162	CbGpPWpGaD
Theobromine—CYP1A2—Aryl Hydrocarbon Receptor—MYC—urinary bladder cancer	0.000624	0.00161	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.000622	0.0016	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—GLI1—urinary bladder cancer	0.000614	0.00158	CbGpPWpGaD
Theobromine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—urinary bladder cancer	0.000611	0.00158	CbGpPWpGaD
Theobromine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—urinary bladder cancer	0.000611	0.00158	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—GSTZ1—urinary bladder cancer	0.00059	0.00152	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by NGF—SRC—urinary bladder cancer	0.000582	0.0015	CbGpPWpGaD
Theobromine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—urinary bladder cancer	0.000582	0.0015	CbGpPWpGaD
Theobromine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—urinary bladder cancer	0.000582	0.0015	CbGpPWpGaD
Theobromine—CYP1A2—Biological oxidations—GSTP1—urinary bladder cancer	0.000579	0.00149	CbGpPWpGaD
Theobromine—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—urinary bladder cancer	0.000577	0.00149	CbGpPWpGaD
Theobromine—CYP1A2—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000571	0.00147	CbGpPWpGaD
Theobromine—ADORA2A—Circadian rythm related genes—TP53—urinary bladder cancer	0.000568	0.00147	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—GSTO2—urinary bladder cancer	0.000559	0.00144	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—NAT1—urinary bladder cancer	0.000559	0.00144	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—RBX1—urinary bladder cancer	0.000545	0.00141	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—RBX1—urinary bladder cancer	0.000538	0.00139	CbGpPWpGaD
Theobromine—ADORA2A—NGF signalling via TRKA from the plasma membrane—HRAS—urinary bladder cancer	0.000532	0.00137	CbGpPWpGaD
Theobromine—CYP1A2—Biological oxidations—GSTM1—urinary bladder cancer	0.000532	0.00137	CbGpPWpGaD
Theobromine—CYP1A2—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000525	0.00135	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—TSC1—urinary bladder cancer	0.000512	0.00132	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—UGT2B7—urinary bladder cancer	0.000512	0.00132	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by NGF—EGFR—urinary bladder cancer	0.00051	0.00132	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—TSC1—urinary bladder cancer	0.000506	0.00131	CbGpPWpGaD
Theobromine—ADORA2A—GPCR ligand binding—CXCL8—urinary bladder cancer	0.000494	0.00128	CbGpPWpGaD
Theobromine—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—urinary bladder cancer	0.00049	0.00127	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—JAG1—urinary bladder cancer	0.000488	0.00126	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by NGF—KRAS—urinary bladder cancer	0.000482	0.00124	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—JAG1—urinary bladder cancer	0.000482	0.00124	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—CYP4B1—urinary bladder cancer	0.000461	0.00119	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—SLC19A1—urinary bladder cancer	0.000435	0.00112	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—PRSS3—urinary bladder cancer	0.000424	0.00109	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—RBX1—urinary bladder cancer	0.000421	0.00109	CbGpPWpGaD
Theobromine—ADORA1—GPCR downstream signaling—RHOA—urinary bladder cancer	0.000412	0.00106	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by NGF—HRAS—urinary bladder cancer	0.00041	0.00106	CbGpPWpGaD
Theobromine—PDE4B—GPCR downstream signaling—RHOA—urinary bladder cancer	0.000407	0.00105	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—TSC1—urinary bladder cancer	0.000395	0.00102	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—S100B—urinary bladder cancer	0.000395	0.00102	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—S100B—urinary bladder cancer	0.00039	0.00101	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—JAG1—urinary bladder cancer	0.000376	0.000972	CbGpPWpGaD
Theobromine—ADORA1—Signaling by GPCR—RHOA—urinary bladder cancer	0.000374	0.000966	CbGpPWpGaD
Theobromine—PDE4B—Signaling by GPCR—RHOA—urinary bladder cancer	0.00037	0.000955	CbGpPWpGaD
Theobromine—ADORA1—GPCR downstream signaling—CXCL8—urinary bladder cancer	0.000362	0.000934	CbGpPWpGaD
Theobromine—PDE4B—GPCR downstream signaling—CXCL8—urinary bladder cancer	0.000358	0.000923	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—NCOR1—urinary bladder cancer	0.000355	0.000916	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—GSTZ1—urinary bladder cancer	0.000355	0.000915	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—NCOR1—urinary bladder cancer	0.000351	0.000905	CbGpPWpGaD
Theobromine—ADORA1—GPCR downstream signaling—IL2—urinary bladder cancer	0.000346	0.000892	CbGpPWpGaD
Theobromine—PDE4B—GPCR downstream signaling—IL2—urinary bladder cancer	0.000342	0.000882	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—TYMP—urinary bladder cancer	0.000339	0.000874	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—GSTO2—urinary bladder cancer	0.000336	0.000868	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—NAT1—urinary bladder cancer	0.000336	0.000868	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	0.000331	0.000853	CbGpPWpGaD
Theobromine—ADORA1—Signaling by GPCR—CXCL8—urinary bladder cancer	0.000329	0.000848	CbGpPWpGaD
Theobromine—PDE4B—Signaling by GPCR—CXCL8—urinary bladder cancer	0.000325	0.000838	CbGpPWpGaD
Theobromine—ADORA2A—GPCR downstream signaling—RHOA—urinary bladder cancer	0.000318	0.000821	CbGpPWpGaD
Theobromine—ADORA1—Signaling by GPCR—IL2—urinary bladder cancer	0.000314	0.00081	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—TERT—urinary bladder cancer	0.000313	0.000807	CbGpPWpGaD
Theobromine—PDE4B—Signaling by GPCR—IL2—urinary bladder cancer	0.00031	0.000801	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—TERT—urinary bladder cancer	0.000309	0.000798	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—UGT2B7—urinary bladder cancer	0.000307	0.000794	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—NAT2—urinary bladder cancer	0.000306	0.000791	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—S100B—urinary bladder cancer	0.000305	0.000787	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by GPCR—RHOA—urinary bladder cancer	0.000289	0.000746	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—FGFR3—urinary bladder cancer	0.000287	0.000741	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—FGFR3—urinary bladder cancer	0.000284	0.000732	CbGpPWpGaD
Theobromine—ADORA2A—GPCR downstream signaling—CXCL8—urinary bladder cancer	0.000279	0.000721	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—ESR1—urinary bladder cancer	0.000279	0.00072	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—CYP4B1—urinary bladder cancer	0.000277	0.000715	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—ESR1—urinary bladder cancer	0.000276	0.000711	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—NCOR1—urinary bladder cancer	0.000274	0.000707	CbGpPWpGaD
Theobromine—ADORA2A—GPCR downstream signaling—IL2—urinary bladder cancer	0.000267	0.000689	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—RRM2—urinary bladder cancer	0.000265	0.000683	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—SLC19A1—urinary bladder cancer	0.000261	0.000675	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—PRSS3—urinary bladder cancer	0.000255	0.000658	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by GPCR—CXCL8—urinary bladder cancer	0.000254	0.000655	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—HPGDS—urinary bladder cancer	0.000245	0.000632	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—ENO2—urinary bladder cancer	0.000245	0.000632	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—CREBBP—urinary bladder cancer	0.000244	0.000631	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by GPCR—IL2—urinary bladder cancer	0.000242	0.000626	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—TERT—urinary bladder cancer	0.000242	0.000623	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—CREBBP—urinary bladder cancer	0.000242	0.000623	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—IGF1—urinary bladder cancer	0.000241	0.000623	CbGpPWpGaD
Theobromine—ADORA1—Signaling by GPCR—EGFR—urinary bladder cancer	0.00024	0.00062	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—IGF1—urinary bladder cancer	0.000238	0.000616	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—GSTT1—urinary bladder cancer	0.000238	0.000613	CbGpPWpGaD
Theobromine—PDE4B—Signaling by GPCR—EGFR—urinary bladder cancer	0.000237	0.000612	CbGpPWpGaD
Theobromine—ADORA1—Signaling by GPCR—KRAS—urinary bladder cancer	0.000227	0.000586	CbGpPWpGaD
Theobromine—PDE4B—Signaling by GPCR—KRAS—urinary bladder cancer	0.000224	0.000579	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—FGFR3—urinary bladder cancer	0.000222	0.000572	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—RHOA—urinary bladder cancer	0.000221	0.000571	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—RHOA—urinary bladder cancer	0.000218	0.000564	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—ESR1—urinary bladder cancer	0.000215	0.000556	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—ERBB2—urinary bladder cancer	0.000205	0.000528	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	0.000204	0.000527	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—TYMP—urinary bladder cancer	0.000204	0.000526	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—ERBB2—urinary bladder cancer	0.000202	0.000522	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—NQO1—urinary bladder cancer	0.000197	0.00051	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	0.000196	0.000505	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—CXCL8—urinary bladder cancer	0.000194	0.000501	CbGpPWpGaD
Theobromine—ADORA1—Signaling by GPCR—HRAS—urinary bladder cancer	0.000193	0.000498	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—CXCL8—urinary bladder cancer	0.000192	0.000495	CbGpPWpGaD
Theobromine—PDE4B—Signaling by GPCR—HRAS—urinary bladder cancer	0.000191	0.000492	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—CREBBP—urinary bladder cancer	0.000189	0.000487	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—IGF1—urinary bladder cancer	0.000186	0.000481	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—IL2—urinary bladder cancer	0.000186	0.000479	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by GPCR—EGFR—urinary bladder cancer	0.000185	0.000479	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—NAT2—urinary bladder cancer	0.000184	0.000475	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—IL2—urinary bladder cancer	0.000183	0.000473	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—CCND1—urinary bladder cancer	0.000181	0.000467	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—CCND1—urinary bladder cancer	0.000179	0.000461	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—MMP9—urinary bladder cancer	0.000176	0.000453	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by GPCR—KRAS—urinary bladder cancer	0.000175	0.000452	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—CDKN1A—urinary bladder cancer	0.000175	0.000451	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—PTEN—urinary bladder cancer	0.000175	0.00045	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—MMP9—urinary bladder cancer	0.000173	0.000448	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—CDKN1A—urinary bladder cancer	0.000173	0.000446	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—PTEN—urinary bladder cancer	0.000172	0.000445	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—RHOA—urinary bladder cancer	0.000171	0.000441	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—EP300—urinary bladder cancer	0.000166	0.00043	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—GSTP1—urinary bladder cancer	0.000165	0.000425	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—EP300—urinary bladder cancer	0.000164	0.000425	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—SRC—urinary bladder cancer	0.000162	0.000418	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—SRC—urinary bladder cancer	0.00016	0.000413	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—RRM2—urinary bladder cancer	0.000159	0.00041	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—ERBB2—urinary bladder cancer	0.000158	0.000408	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—TYMS—urinary bladder cancer	0.000153	0.000395	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—NCOR1—urinary bladder cancer	0.000151	0.000391	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—GSTM1—urinary bladder cancer	0.000151	0.000391	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—CXCL8—urinary bladder cancer	0.00015	0.000387	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by GPCR—HRAS—urinary bladder cancer	0.000149	0.000384	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—HPGDS—urinary bladder cancer	0.000147	0.00038	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—ENO2—urinary bladder cancer	0.000147	0.00038	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	0.000146	0.000378	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—MYC—urinary bladder cancer	0.000145	0.000374	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—GPX1—urinary bladder cancer	0.000145	0.000374	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—MYC—urinary bladder cancer	0.000143	0.00037	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—IL2—urinary bladder cancer	0.000143	0.00037	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—GSTT1—urinary bladder cancer	0.000143	0.000369	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—ERCC2—urinary bladder cancer	0.000142	0.000367	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—EGFR—urinary bladder cancer	0.000142	0.000366	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	0.000141	0.000363	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—EGFR—urinary bladder cancer	0.00014	0.000362	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—CCND1—urinary bladder cancer	0.00014	0.00036	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—MMP9—urinary bladder cancer	0.000136	0.00035	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—CDKN1A—urinary bladder cancer	0.000135	0.000349	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—PTEN—urinary bladder cancer	0.000135	0.000348	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—KRAS—urinary bladder cancer	0.000134	0.000346	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—MTHFR—urinary bladder cancer	0.000134	0.000345	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—KRAS—urinary bladder cancer	0.000132	0.000342	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—EP300—urinary bladder cancer	0.000129	0.000332	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—SRC—urinary bladder cancer	0.000125	0.000323	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—TP53—urinary bladder cancer	0.000119	0.000307	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—NQO1—urinary bladder cancer	0.000119	0.000306	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—TP53—urinary bladder cancer	0.000118	0.000304	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	0.000115	0.000297	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—HRAS—urinary bladder cancer	0.000114	0.000294	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—HRAS—urinary bladder cancer	0.000113	0.000291	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—MYC—urinary bladder cancer	0.000112	0.000289	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—EGFR—urinary bladder cancer	0.00011	0.000283	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—PPARG—urinary bladder cancer	0.000108	0.00028	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—CREBBP—urinary bladder cancer	0.000104	0.000269	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—KRAS—urinary bladder cancer	0.000103	0.000267	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	0.0001	0.000259	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—GSTP1—urinary bladder cancer	9.9e-05	0.000256	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	9.58e-05	0.000247	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—TYMS—urinary bladder cancer	9.2e-05	0.000238	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—TP53—urinary bladder cancer	9.2e-05	0.000237	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—NCOR1—urinary bladder cancer	9.1e-05	0.000235	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—GSTM1—urinary bladder cancer	9.1e-05	0.000235	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—HRAS—urinary bladder cancer	8.8e-05	0.000227	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—GPX1—urinary bladder cancer	8.71e-05	0.000225	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—ERCC2—urinary bladder cancer	8.55e-05	0.000221	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—PTGS2—urinary bladder cancer	8.53e-05	0.00022	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—MTHFR—urinary bladder cancer	8.04e-05	0.000208	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—PTEN—urinary bladder cancer	7.44e-05	0.000192	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—EP300—urinary bladder cancer	7.1e-05	0.000183	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—PPARG—urinary bladder cancer	6.52e-05	0.000168	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—CREBBP—urinary bladder cancer	6.26e-05	0.000162	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—PTGS2—urinary bladder cancer	5.13e-05	0.000132	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—PTEN—urinary bladder cancer	4.47e-05	0.000115	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—EP300—urinary bladder cancer	4.27e-05	0.00011	CbGpPWpGaD
